INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 204S204 trades$51.20M
  2. 02SPSaba Capital Management, L.P.73B / 25S · 14 late98 trades$31.71M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08SLSpeiser Michael L0B / 35S35 trades$14.00M
  9. 09RARothblatt Martine A0B / 33S33 trades$5.50M
  10. 10RJRubinstein Julie0B / 33S33 trades$5.33M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  7. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  8. SELLULCCFrontier Group Holdings, Inc.Nov 5 – Nov 117 insiders$1.31M

Form 4 transactions

19,519 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$219K
856 sh
Jan 8, 2026
Page 392 of 488
← PrevNext →
Jan 12, 2026
traded Jan 8, 2026
+4d
SEC Form 4

Evidence

15
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.03M
41.2K sh
Jan 9, 2026Jan 12, 2026
traded Jan 9, 2026
+3dSEC Form 4

Evidence

14
UC
Ugwumba Chidozie10% Owner
CLNNClene Inc.
Open-market sale
SELL$19K
3,195 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

14
KB
Klein Matthew B.Director, CHIEF EXECUTIVE OFFICER
PTCTPTC THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$192K
2,514 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

13
SB
Slowe Christopher BrianChief Technology Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
100 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

12
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$842K
33.8K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

11
MJ
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER
OMCLOMNICELL, INC.
Open-market sale · 10b5-1 plan
SELL$305K
6,106 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

11
SM
Schlosser MarioDirector, President of Technology & CTO
OSCROscar Health, Inc.
Open-market sale · 10b5-1 plan
SELL$407K
23.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

9
LP
Lyssikatos Joseph PCHIEF SCIENTIFIC OFFICER
ELVNEnliven Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$151K
7,500 sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

8
DS
Das SouvikChief Technology Officer
CWANClearwater Analytics Holdings, Inc.
Open-market sale · 10b5-1 plan
SELL$241K
10.0K sh
Jan 8, 2026Jan 12, 2026
traded Jan 8, 2026
+4dSEC Form 4

Evidence

8
TD
Tesh Thomas DChief Admin. Officer
ROLROLLINS INC
Open-market sale · 10b5-1 plan
SELL$144K
2,396 sh
Jan 9, 2026Jan 12, 2026
traded Jan 9, 2026
+3dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$747K
45.0K sh
Jan 12, 2026Jan 12, 2026
traded Jan 12, 2026
+0dSEC Form 4

Evidence

45
GS
Gillai SaarDirector
SMTCSEMTECH CORP
Open-market sale
SELL$271K
3,600 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

44
MB
Mcrae Matthew BlakeDirector, CEO
ARLOArlo Technologies, Inc.
Open-market sale
SELL$1.23M
90.1K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

41
ZL
Zitkus LesterSVP, Land
GPORGULFPORT ENERGY CORP
Open-market sale
SELL$300K
1,606 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

41
ZL
Zitkus LesterSVP, Land
GPORGULFPORT ENERGY CORP
Open-market sale
SELL$450K
2,439 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

41
BJ
Binder Kurtis JosephCHIEF FINANCIAL OFFICER
ARLOArlo Technologies, Inc.
Open-market sale
SELL$754K
55.0K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

38
ZL
Zitkus LesterSVP, Land
GPORGULFPORT ENERGY CORP
Open-market sale
SELL$131K
700 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

35
PT
Parang TourajDirector, President & COO
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$57K
4,008 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

35
KA
Kashani AliDirector, Chief Executive Officer
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$130K
9,088 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

34
KK
Krumm KevinChief Financial Officer
FLEXFLEX LTD.
Open-market sale
SELL$1.30M
21.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

33
BB
Busse BrianGENERAL COUNSEL
ARLOArlo Technologies, Inc.
Open-market sale
SELL$258K
18.8K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

32
BH
Bernstein HaroldPresident, R&D & CMO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$1.01M
25.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

32
AE
Abraham EuanChief Hardware & Mftg Offcr
SERVServe Robotics Inc. /DE/
Open-market sale
SELL$17K
1,171 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

32
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Open-market sale
SELL$639K
14.3K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

31
SA
Sutherland Vanessa AllenEVP, GC and Secretary
PSXPhillips 66
Open-market sale
SELL$637K
4,394 sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

30
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$5.64M
21.7K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

30
SA
Schacterle AmyChief Regulatory Officer
ABOSAcumen Pharmaceuticals, Inc.
Open-market sale
SELL$2,176
1,097 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

29
DN
Doherty John N.EVP, CFO
BFLYButterfly Network, Inc.
Open-market sale
SELL$240K
60.2K sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

29
LF
Lizzul Paul F.Chief Medical Officer
ANABANAPTYSBIO, INC
Open-market sale
SELL$163K
3,650 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

29
CJ
Connelly JackPortfolio Manager
IQIInvesco Quality Municipal Income Trust
Open-market sale
SELL$39K
3,900 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

26
DJ
Doherty James J.President and CDO
ABOSAcumen Pharmaceuticals, Inc.
Open-market sale
SELL$3,379
1,700 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

26
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$1.63M
6,250 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence

26
DJ
Doherty James J.President and CDO
ABOSAcumen Pharmaceuticals, Inc.
Open-market sale
SELL$12K
6,467 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

23
LS
Lee Benjamin SeongChief Legal Officer
RDDTReddit, Inc.
Open-market sale · 10b5-1 plan
SELL$864K
3,320 sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

22
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$1.07M
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

22
ST
Schwartz Richard ToddDirector, Chief Executive Officer
RSIRush Street Interactive, Inc.
Open-market sale · 10b5-1 plan
SELL$1.07M
55.6K sh
Jan 9, 2026Jan 9, 2026
traded Jan 9, 2026
+0dSEC Form 4

Evidence

21
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$696K
10.8K sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

21
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$585K
8,938 sh
Jan 8, 2026Jan 9, 2026
traded Jan 8, 2026
+1dSEC Form 4

Evidence

21
TM
Ting Hock MingDirector
TRTTRIO-TECH INTERNATIONAL
Open-market sale
SELL$15K
2,000 sh
Jan 7, 2026Jan 9, 2026
traded Jan 7, 2026
+2dSEC Form 4

Evidence